Select a State

Global health R&D delivers for Mississippi

US government investment in global health R&D has delivered

$19.4 million
to Mississippi research institutions
200+ new jobs
for Mississippi

Neglected diseases in Mississippi

Chikungunya cases
9
Dengue cases
6
HIV diagnoses
4,334
Malaria cases
18
Tuberculosis cases
799
West Nile cases
594
Zika cases
25

Mississippi's top USG-funded global health R&D institutions

University of Mississippi (including University of Mississippi Medical Center)
$18.1 million
University of Southern Mississippi
$724 thousand
Jackson State University
$269 thousand
Mississippi State University
$202 thousand
Mississippi University for Women
$164 thousand

Mississippi industry in global health R&D

ElSohly Laboratories
Location(s):
Oxford
Emergent Biosolutions
Location(s):
Hattiesburg

Mississippi's top areas of global health R&D by USG funding

86.9%
Malaria
4.0%
Diarrheal diseases
4.8%
Hepatitis C
3.4%
Neglected tropical diseases
Dengue
Kinetoplastids
0.9%
Other
HIV/AIDS
Tuberculosis

Global health R&D at work in Mississippi

The University of Mississippi School of Pharmacy is working to make a common malaria drug safer. Primaquine is an inexpensive drug that is highly effective against malaria. However, people with a certain enzyme deficiency can have a life-threatening reaction to the drug. This deficiency is common in regions where malaria is found, so many public health programs are reluctant to use primaquine. If the researchers can alter the drug to stop the reaction, it could be used more widely. Malaria infects more than 200 million people each year, killing almost half a million, most of whom are young children.

Footnotes